\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ wbc\\ count\\.\\ \\ ua\\ had\\ rbc\\'s\\ but\\ inconclusive\\ because\\ patient\\ currently\\ menstruating\\.\\ right\\ cva\\ tenderness\\.\ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ with\\ low\\-molecular\\-weight\\ heparin\\ \\ for\\ 5\\ days\\,\\ followed\\ by\\ warfarin\\ therapy\\ \\(target\\ inr\\ of\\ 2\\.0\\-3\\.0\\)\\ for\\ 6\\ months\\.\ \(0\)\
\-\ initial\\ non\\-con\\ stone\\ protocol\\ ct\\ exam\\:\\ there\\ was\\ no\\ renal\\ calculi\\,\\ hydronephrosis\\ or\\ further\\ renal\\ abnormality\\ present\\.\\ \\ on\\ the\\ images\\ through\\ the\\ lung\\ bases\\,\\ there\\ is\\ a\\ peripheral\\ wedge\\ shaped\\ opacity\\ in\\ the\\ right\\ lower\\ lobe\\ posterior\\ basal\\ segment\\.\\ \\ possibility\\ of\\ pulmonary\\ infarct\\ was\\ raised\\ by\\ the\\ radiologist\\,\\ ct\\ pulmonary\\ angiogram\\ was\\ recommended\\.\ \(0\)\
\-\ ct\\ pulmonary\\ angiogram\\:\\ \\ within\\ the\\ lul\\ and\\ the\\ lingular\\ segmental\\ pulmonary\\ arteries\\ are\\ filling\\ defects\\ consistent\\ with\\ pulmonary\\ emboli\\.\\ \\ additionally\\ in\\ a\\ subsegmental\\ branch\\ of\\ the\\ rll\\,\\ there\\ is\\ a\\ filling\\ defect\\ consistent\\ with\\ another\\ pulmonary\\ embolism\\.\\ \\ on\\ the\\ lung\\ windows\\,\\ distal\\ to\\ this\\ pe\\,\\ again\\ identified\\ is\\ a\\ wedge\\ shaped\\,\\ peripherally\\ based\\ opacity\\,\\ consistent\\ with\\ a\\ pulmonary\\ infarct\\.\ \(0\)\
\-\ pulmonary\\ embolism\\ with\\ rll\\ pulmonary\\ infarct\\.\ \(0\)\
\-\ after\\ the\\ ct\\ pe\\ protocol\\,\\ no\\ ddx\\.\ \(0\)\
\-\ 34\\ year\\ old\\ female\\ smoker\\,\\ on\\ ocps\\,\\ presents\\ to\\ the\\ er\\ with\\ right\\ flank\\ pain\\ and\\ remote\\ history\\ of\\ renal\\ stone\\ disease\\.\ \(0\)\
\-\ this\\ particular\\ case\\ was\\ interesting\\ because\\ the\\ patient\\ initially\\ presented\\ as\\ \\"renal\\ colic\\"\\,\\ however\\,\\ it\\ turned\\ out\\ that\\ her\\ flank\\ pain\\ was\\ coming\\ from\\ a\\ right\\ lower\\ lobe\\ pulmonary\\ infarction\\.\ \(0\)\
\-\ ct\\-pathologic\\ correlation\\ has\\ demonstrated\\ that\\ the\\ finding\\ of\\ wedge\\-shaped\\ opacity\\ at\\ ct\\ is\\ likely\\ to\\ represent\\ pulmonary\\ infarction\\,\\ that\\ is\\,\\ an\\ area\\ of\\ lung\\ filled\\ with\\ red\\ blood\\ cells\\ with\\ or\\ without\\ tissue\\ necrosis\\.\\ the\\ triangular\\ configuration\\ corresponds\\ to\\ increased\\ attenuation\\ within\\ several\\ affected\\ secondary\\ pulmonary\\ lobules\\,\\ with\\ a\\ broad\\ base\\ abutting\\ a\\ peripheral\\ pleural\\ surface\\ and\\ often\\ with\\ a\\ truncated\\ apex\\.\\ the\\ reported\\ prevalence\\ of\\ pulmonary\\ infarction\\ after\\ pe\\ has\\ been\\ estimated\\ to\\ be\\ 10\\%\\â\\€\\“15\\%\\ in\\ autopsy\\ series\\.\\ in\\ the\\ below\\ referenced\\ study\\,\\ they\\ showed\\ a\\ higher\\ prevalence\\ of\\ 25\\%\\ for\\ wedge\\-shaped\\ opacity\\ at\\ ct\\.\\ \\ this\\ may\\ reflect\\ differences\\ in\\ the\\ interval\\ between\\ the\\ embolic\\ event\\ and\\ the\\ ct\\ examination\\.\\ owing\\ to\\ subsequent\\ resolution\\ of\\ the\\ parenchymal\\ hemorrhage\\ associated\\ with\\ some\\ opacities\\,\\ a\\ greater\\ number\\ of\\ acute\\ pulmonary\\ infarcts\\ might\\ be\\ detected\\ on\\ ct\\ scans\\ than\\ in\\ autopsy\\ specimens\\.\ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ a\\.\\ shah\\ et\\ al\\.\\,\\ \\ parenchymal\\ and\\ pleural\\ findings\\ in\\ patients\\ with\\ and\\ patients\\ without\\ acute\\ pulmonary\\ embolism\\ detected\\ at\\ spiral\\ ct\\;\\ \\ radiology\\.\\ 1999\\;211\\:147\\-153\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.0864855765665149\ \(0\)\
\-\ opacity\\:\\ 0\\.03690749984629525\ \(0\)\
\-\ embolism\\:\\ 0\\.02896620856168727\ \(0\)\
\-\ autopsy\\:\\ 0\\.027911915481416704\ \(0\)\
\-\ rll\\:\\ 0\\.027367882984158584\ \(0\)\
\-\ wedge\\-shaped\\:\\ 0\\.02711814986050835\ \(0\)\
\-\ pe\\:\\ 0\\.026596660611172683\ \(0\)\
\-\ infarct\\:\\ 0\\.02627000856665281\ \(0\)\
\-\ wedge\\:\\ 0\\.02516500043408787\ \(0\)\
\-\ ct\\:\\ 0\\.02484464868482306\ \(0\)\
\-\ prevalence\\:\\ 0\\.024296398902896463\ \(0\)\
\-\ infarction\\:\\ 0\\.02419751809349716\ \(0\)\
\-\ renal\\:\\ 0\\.023718018932638054\ \(0\)\
\-\ protocol\\:\\ 0\\.02122868692281936\ \(0\)\
\-\ detected\\:\\ 0\\.020838121620149322\ \(0\)\
\-\ low\\-molecular\\-weight\\:\\ 0\\.020359164951423783\ \(0\)\
\-\ 2\\.0\\-3\\.0\\:\\ 0\\.020359164951423783\ \(0\)\
\-\ ct\\-pathologic\\:\\ 0\\.020359164951423783\ \(0\)\
\-\ 211\\:147\\-153\\:\\ 0\\.020359164951423783\ \(0\)\
\-\ shaped\\:\\ 0\\.02009057877742224\ \(0\)\
\-\ stone\\:\\ 0\\.019635890219393357\ \(0\)\
\-\ parenchymal\\:\\ 0\\.01940137601443528\ \(0\)\
\-\ angiogram\\:\\ 0\\.019091857722135234\ \(0\)\
\-\ \\â\\€\\“15\\:\\ 0\\.018758363148744926\ \(0\)\
\-\ owing\\:\\ 0\\.018758363148744926\ \(0\)\
\-\ flank\\:\\ 0\\.018566872417412273\ \(0\)\
\-\ non\\-con\\:\\ 0\\.017821954123090965\ \(0\)\
\-\ referenced\\:\\ 0\\.017821954123090965\ \(0\)\
\-\ menstruating\\:\\ 0\\.017157561346066066\ \(0\)\
\-\ lung\\:\\ 0\\.01714890845431002\ \(0\)\
\-\ truncated\\:\\ 0\\.016642218271437408\ \(0\)\
\-\ shah\\:\\ 0\\.01622115232041211\ \(0\)\
\-\ filling\\:\\ 0\\.015890254116777518\ \(0\)\
\-\ ocps\\:\\ 0\\.015865146131434606\ \(0\)\
\-\ lobules\\:\\ 0\\.015865146131434606\ \(0\)\
\-\ pleural\\:\\ 0\\.015327252649761184\ \(0\)\
\-\ subsegmental\\:\\ 0\\.015041416468758551\ \(0\)\
\-\ differences\\:\\ 0\\.015041416468758551\ \(0\)\
\-\ lingular\\:\\ 0\\.01482130058006496\ \(0\)\
\-\ colic\\:\\ 0\\.01482130058006496\ \(0\)\
\-\ inconclusive\\:\\ 0\\.014620350517733251\ \(0\)\
\-\ reflect\\:\\ 0\\.014620350517733251\ \(0\)\
\-\ consistent\\:\\ 0\\.014517078075042978\ \(0\)\
\-\ lul\\:\\ 0\\.014435494379919079\ \(0\)\
\-\ peripheral\\:\\ 0\\.014281447214845807\ \(0\)\
\-\ coming\\:\\ 0\\.014264344328755748\ \(0\)\
\-\ warfarin\\:\\ 0\\.01410500744310459\ \(0\)\
\-\ al\\.\\:\\ 0\\.01410500744310459\ \(0\)\
\-\ turned\\:\\ 0\\.013955957740708352\ \(0\)\
\-\ specimens\\:\\ 0\\.013815947066767396\ \(0\)\
\-\ \\%\\:\\ 0\\.013810538337270261\ \(0\)\
\-\ because\\:\\ 0\\.013808398690928628\ \(0\)\
\-\ was\\:\\ 0\\.013694376751228917\ \(0\)\
\-\ spiral\\:\\ 0\\.013559074930254175\ \(0\)\
\-\ cva\\:\\ 0\\.01332793530310179\ \(0\)\
\-\ calculi\\:\\ 0\\.013220498777386102\ \(0\)\
\-\ abutting\\:\\ 0\\.013220498777386102\ \(0\)\
\-\ raised\\:\\ 0\\.012582500217043935\ \(0\)\
\-\ corresponds\\:\\ 0\\.012582500217043935\ \(0\)\
\-\ \\,\\:\\ 0\\.012503929123200341\ \(0\)\
\-\ inr\\:\\ 0\\.012355155938029494\ \(0\)\
\-\ heparin\\:\\ 0\\.012148199451448231\ \(0\)\
\-\ windows\\:\\ 0\\.012019862612753519\ \(0\)\
\-\ embolic\\:\\ 0\\.012019862612753519\ \(0\)\
\-\ target\\:\\ 0\\.011898283551586264\ \(0\)\
\-\ peripherally\\:\\ 0\\.011782786044485427\ \(0\)\
\-\ smoker\\:\\ 0\\.011727133500422931\ \(0\)\
\-\ interesting\\:\\ 0\\.011672790550283916\ \(0\)\
\-\ triangular\\:\\ 0\\.011467369104518337\ \(0\)\
\-\ remote\\:\\ 0\\.011418746912375537\ \(0\)\
\-\ estimated\\:\\ 0\\.011418746912375537\ \(0\)\
\-\ rbc\\:\\ 0\\.01137112731144543\ \(0\)\
\-\ radiologist\\:\\ 0\\.011324469788772175\ \(0\)\
\-\ bases\\:\\ 0\\.011278736238434577\ \(0\)\
\-\ might\\:\\ 0\\.011189899562157914\ \(0\)\
\-\ 1999\\:\\ 0\\.011189899562157914\ \(0\)\
\-\ a\\.\\:\\ 0\\.011062740723398034\ \(0\)\
\-\ configuration\\:\\ 0\\.011021864101921358\ \(0\)\
\-\ event\\:\\ 0\\.010903403837746878\ \(0\)\
\-\ correlation\\:\\ 0\\.010865229930238307\ \(0\)\
\-\ emboli\\:\\ 0\\.010683287949053285\ \(0\)\
\-\ branch\\:\\ 0\\.010683287949053285\ \(0\)\
\-\ lobe\\:\\ 0\\.010620440406113322\ \(0\)\
\-\ infarcts\\:\\ 0\\.01061434346140968\ \(0\)\
\-\ reference\\:\\ 0\\.01061434346140968\ \(0\)\
\-\ particular\\:\\ 0\\.0105806279893054\ \(0\)\
\-\ ua\\:\\ 0\\.010482337886721578\ \(0\)\
\-\ ddx\\:\\ 0\\.010419060810074661\ \(0\)\
\-\ segmental\\:\\ 0\\.01035747132489646\ \(0\)\
\-\ red\\:\\ 0\\.010297481748907406\ \(0\)\
\-\ opacities\\:\\ 0\\.010297481748907406\ \(0\)\
\-\ broad\\:\\ 0\\.010239011060721977\ \(0\)\
\-\ that\\:\\ 0\\.010226194424195081\ \(0\)\
\-\ patients\\:\\ 0\\.010215125170281874\ \(0\)\
\-\ apex\\:\\ 0\\.010153990337574827\ \(0\)\
\-\ a\\:\\ 0\\.010075283648971395\ \(0\)\
\-\ possibility\\:\\ 0\\.009966994812092917\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.009941475559929904\ \(0\)\
\-\ number\\:\\ 0\\.0098421282502678\ \(0\)\
\-\ series\\:\\ 0\\.009817945109696679\ \(0\)\
\-\ 34\\:\\ 0\\.009794012576127288\ \(0\)\
\-\ acute\\:\\ 0\\.009745401058228615\ \(0\)\
\-\ higher\\:\\ 0\\.00967793443575572\ \(0\)\
\-\ interval\\:\\ 0\\.00967793443575572\ \(0\)\
\-\ again\\:\\ 0\\.009482651784420704\ \(0\)\
\-\ \\;\\:\\ 0\\.009355294172991194\ \(0\)\
\-\ without\\:\\ 0\\.009293363355003048\ \(0\)\
\-\ scans\\:\\ 0\\.009189922672090116\ \(0\)\
\-\ filled\\:\\ 0\\.009171665906484773\ \(0\)\
\-\ defects\\:\\ 0\\.009065056110264999\ \(0\)\
\-\ basal\\:\\ 0\\.008996622397548205\ \(0\)\
\-\ lower\\:\\ 0\\.00887696105941738\ \(0\)\
\-\ there\\:\\ 0\\.008810962284976827\ \(0\)\
\-\ surface\\:\\ 0\\.008711531886945154\ \(0\)\
\-\ represent\\:\\ 0\\.008667259563370742\ \(0\)\
\-\ segment\\:\\ 0\\.008609519835413658\ \(0\)\
\-\ count\\:\\ 0\\.008581182439127713\ \(0\)\
\-\ below\\:\\ 0\\.008567143071745768\ \(0\)\
\-\ additionally\\:\\ 0\\.00855318853489597\ \(0\)\
\-\ affected\\:\\ 0\\.008539317809583703\ \(0\)\
\-\ resolution\\:\\ 0\\.008511823808414375\ \(0\)\
\-\ another\\:\\ 0\\.00848465327358854\ \(0\)\
\-\ radiology\\:\\ 0\\.008340673757251045\ \(0\)\
\-\ right\\:\\ 0\\.00832916128508468\ \(0\)\
\-\ recommended\\:\\ 0\\.008181336871599889\ \(0\)\
\-\ arteries\\:\\ 0\\.008169523706087716\ \(0\)\
\-\ after\\:\\ 0\\.008166287309973222\ \(0\)\
\-\ et\\:\\ 0\\.008077132633076863\ \(0\)\
\-\ initially\\:\\ 0\\.008032287169203648\ \(0\)\
\-\ at\\:\\ 0\\.00802145371476882\ \(0\)\
\-\ 25\\:\\ 0\\.00797742784816876\ \(0\)\
\-\ attenuation\\:\\ 0\\.007934459746942353\ \(0\)\
\-\ cells\\:\\ 0\\.007913271810969971\ \(0\)\
\-\ \\:\\:\\ 0\\.007831003344046178\ \(0\)\
\-\ currently\\:\\ 0\\.007820260496563642\ \(0\)\
\-\ necrosis\\:\\ 0\\.007790070931742966\ \(0\)\
\-\ base\\:\\ 0\\.007730850537716783\ \(0\)\
\-\ subsequent\\:\\ 0\\.0076826344060272785\ \(0\)\
\-\ er\\:\\ 0\\.007570864103805916\ \(0\)\
\-\ within\\:\\ 0\\.007529475327418391\ \(0\)\
\-\ based\\:\\ 0\\.007525843792764343\ \(0\)\
\-\ greater\\:\\ 0\\.007412739856051965\ \(0\)\
\-\ has\\:\\ 0\\.007412009101590198\ \(0\)\
\-\ defect\\:\\ 0\\.0073874072200922096\ \(0\)\
\-\ abnormality\\:\\ 0\\.0072807342813638615\ \(0\)\
\-\ wbc\\:\\ 0\\.0071941682461335145\ \(0\)\
\-\ reported\\:\\ 0\\.0071941682461335145\ \(0\)\
\-\ they\\:\\ 0\\.007110730084266296\ \(0\)\
\-\ identified\\:\\ 0\\.0070518869311462385\ \(0\)\
\-\ in\\:\\ 0\\.0068124263533066625\ \(0\)\
\-\ on\\:\\ 0\\.006687214894830745\ \(0\)\
\-\ this\\:\\ 0\\.006659149283931638\ \(0\)\
\-\ 10\\:\\ 0\\.006652711843757299\ \(0\)\
\-\ followed\\:\\ 0\\.006616341504338964\ \(0\)\
\-\ by\\:\\ 0\\.006572151978036373\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.006568721903408859\ \(0\)\
\-\ initial\\:\\ 0\\.006539450677319418\ \(0\)\
\-\ out\\:\\ 0\\.006522064380735603\ \(0\)\
\-\ study\\:\\ 0\\.006493374958106141\ \(0\)\
\-\ is\\:\\ 0\\.006492965108368657\ \(0\)\
\-\ showed\\:\\ 0\\.00647067729312632\ \(0\)\
\-\ the\\:\\ 0\\.006385648254209044\ \(0\)\
\-\ finding\\:\\ 0\\.00636041918022744\ \(0\)\
\-\ several\\:\\ 0\\.006344325255709902\ \(0\)\
\-\ often\\:\\ 0\\.006296705654779798\ \(0\)\
\-\ further\\:\\ 0\\.006275852521478656\ \(0\)\
\-\ between\\:\\ 0\\.0062551859958989466\ \(0\)\
\-\ area\\:\\ 0\\.006239806568439416\ \(0\)\
\-\ examination\\:\\ 0\\.006134926178925093\ \(0\)\
\-\ be\\:\\ 0\\.006086636135537778\ \(0\)\
\-\ days\\:\\ 0\\.006048670429958378\ \(0\)\
\-\ tenderness\\:\\ 0\\.006002106981250885\ \(0\)\
\-\ some\\:\\ 0\\.005992905898075656\ \(0\)\
\-\ patient\\:\\ 0\\.005934817073323704\ \(0\)\
\-\ her\\:\\ 0\\.005933976116593385\ \(0\)\
\-\ to\\:\\ 0\\.005917802888355468\ \(0\)\
\-\ treated\\:\\ 0\\.0059072767576994435\ \(0\)\
\-\ 6\\:\\ 0\\.00589404194312904\ \(0\)\
\-\ demonstrated\\:\\ 0\\.005790808273572673\ \(0\)\
\-\ 5\\:\\ 0\\.0057740425460604235\ \(0\)\
\-\ through\\:\\ 0\\.0056049815667918446\ \(0\)\
\-\ likely\\:\\ 0\\.005566489528719761\ \(0\)\
\-\ secondary\\:\\ 0\\.0055173902228840815\ \(0\)\
\-\ however\\:\\ 0\\.005495076340870832\ \(0\)\
\-\ months\\:\\ 0\\.005390164652863897\ \(0\)\
\-\ blood\\:\\ 0\\.005386630652446419\ \(0\)\
\-\ presented\\:\\ 0\\.005379578833769998\ \(0\)\
\-\ been\\:\\ 0\\.005369041315159332\ \(0\)\
\-\ distal\\:\\ 0\\.005365539466388052\ \(0\)\
\-\ therapy\\:\\ 0\\.005276306688777397\ \(0\)\
\-\ than\\:\\ 0\\.005171013521751209\ \(0\)\
\-\ for\\:\\ 0\\.005051557611843292\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0048501963917593925\ \(0\)\
\-\ increased\\:\\ 0\\.004827909426789043\ \(0\)\
\-\ pain\\:\\ 0\\.004820361050950276\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00475692725631003\ \(0\)\
\-\ tissue\\:\\ 0\\.004677647086495597\ \(0\)\
\-\ associated\\:\\ 0\\.0046569574178006974\ \(0\)\
\-\ or\\:\\ 0\\.0046259711268531525\ \(0\)\
\-\ posterior\\:\\ 0\\.004548818819174246\ \(0\)\
\-\ present\\:\\ 0\\.004457295043722127\ \(0\)\
\-\ it\\:\\ 0\\.004436139456196343\ \(0\)\
\-\ \\'s\\:\\ 0\\.004351146924635208\ \(0\)\
\-\ exam\\:\\ 0\\.004335413256234499\ \(0\)\
\-\ may\\:\\ 0\\.0043287029304806554\ \(0\)\
\-\ case\\:\\ 0\\.004317562200617253\ \(0\)\
\-\ had\\:\\ 0\\.004258313670301867\ \(0\)\
\-\ but\\:\\ 0\\.004209014552040502\ \(0\)\
\-\ findings\\:\\ 0\\.004200547195819768\ \(0\)\
\-\ female\\:\\ 0\\.00405718307493726\ \(0\)\
\-\ presents\\:\\ 0\\.0040315110750760415\ \(0\)\
\-\ no\\:\\ 0\\.003974337878539501\ \(0\)\
\-\ images\\:\\ 0\\.003785828849767561\ \(0\)\
\-\ with\\:\\ 0\\.003242609960920732\ \(0\)\
\-\ disease\\:\\ 0\\.003225721804193312\ \(0\)\
\-\ normal\\:\\ 0\\.003093793197688455\ \(0\)\
\-\ as\\:\\ 0\\.002985167450101912\ \(0\)\
\-\ from\\:\\ 0\\.002924793794813423\ \(0\)\
\-\ an\\:\\ 0\\.002729018162320392\ \(0\)\
\-\ history\\:\\ 0\\.002725668678307352\ \(0\)\
\-\ of\\:\\ 0\\.0026906189560736357\ \(0\)\
\-\ are\\:\\ 0\\.0026902398903685953\ \(0\)\
\-\ and\\:\\ 0\\.002494351118691249\ \(0\)\
\-\ year\\:\\ 0\\.00220809531009911\ \(0\)\
\-\ old\\:\\ 0\\.002020634172892043\ \(0\)\
\-\ \\.\\:\\ 0\\.0017216865081853853\ \(0\)\
\-\ \\(\\:\\ 0\\.0016682718850897472\ \(0\)\
\-\ \\)\\:\\ 0\\.0016478930533794574\ \(0\)\
